ARCA biopharma's (ABIO) Richard Brewer Will Assume Role of Chairman And Resign As CEO
More News related to ABIO
- InvestorSoup.com Issues Technical Trading Outlook for ARCA biopharma Inc.
- Unusual 11 Mid-Day Movers 11/24: IWA, DRAM, ABG, TIXC Higher; WH, WMG, ABIO, NYNY Lower
- Morning Movers 11/24: IWA, SEED, FEED, AEZS Higher; WH, ORS, ABIO, GRO, LONG Lower
- Unusual 11 Mid-Day Movers 11/23: ABIO, SEED, FNET, CDTI Higher; NYNY, GGR, TTIL, PEET Lower
- Morning Movers 11/23: ABIO, SEED, FIF, FNET, DDRX, JOBS Higher; BBI, CGA, BOFL, CEPH Lower
More News related to Management Changes
- Green Plains Renewable (GPRE) Appoints Jeffrey Briggs to COO
- EnergySolutions (ES) Announces Resignation of CFO Strawbridge
- Tredegar Corp. (TG) CEO Gottwald to Retire; Several Management Changes Made
- Community Partners Bancorp (CPBC) Completes Management Succession Plan
- Cohu (COHU) Elects Steve Bilodeau to Board of Directors
ARCA biopharma, Inc. (Nasdaq: ABIO) announced changes to its management team to reflect the Company's recent change in commercial strategy to seek alternatives for the potential commercialization of Gencaro. Richard B. Brewer will assume the role of Chairman of the Board of Directors and resign as Chief Executive Officer. Michael R. Bristow, will become President and Chief Executive Officer, a position he previously held with ARCA prior to Mr. Brewer joining the Company. Dr. Bristow will resign as Chairman but will remain a member of the Board of Directors. These changes will be effective on July 10, 2009.
Related Categories
Management ChangesStocks Mentioned
-0.19Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
